ATP-citrate lyase (ACLY) inhibitors as therapeutic agents: a patenting perspective

.

Source: Expert Opinion on Therapeutic Patents - April 25, 2022 Category: Drugs & Pharmacology Authors: Carlotta Granchi Source Type: research